Recursion Pharmaceuticals, Inc. Financial Ratios — RXRX

Profitability (USD)

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-46.56	-69.12	-61.89	-59.54
Return on Assets (%)	- -	-43.5	-41.03	-36.52	-48.42	-44.11	-44.12
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	100	100	-21.66	2.94	22.65	4.45
EBITDA Margin (%)	-3,503.92	-2,363.67	-1,743.7	-589.63	-742.22	-756.58	-760.12
Operating Margin (%)	-3,649.39	-2,479.2	-1,827.75	-619.26	-797.84	-818.98	-872.83
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-756.97	-794.67	-868.48
Profit Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-747.71	-792.75	-868.29
Net Income to Common Margin (%)	-3,616.54	-2,549.25	-1,864.79	-603.5	-747.71	-792.75	-868.29
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-46.56	-69.12	-61.89	-59.54

Credit (USD)

Credit Ratios API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	16	16	11	51	51	108	78
ST Debt	1	2	2	6	6	22	22
LT Debt	16	14	10	45	45	86	56
Total Debt/EBITDA	-0.27	-0.19	-0.07	-0.22	-0.16	-0.25	-0.14
Net Debt/EBITDA	0.96	3.09	1.63	2.35	1.2	1.28	1.28
Total Debt/EBIT	-0.26	-0.19	-0.06	-0.21	-0.14	-0.23	-0.12
Net Debt/EBIT	0.92	2.95	1.56	2.24	1.12	1.18	1.12
EBITDA to Interest Expense	-94.41	-59.32	-59.07	-4,254.02	-3,357.3	-281.49	-311.84
EBITDA-CapEx/Interest Expense	-100.57	-64.27	-72.55	-4,933.27	-3,486.7	-292.34	-316.61
EBIT to Interest Expense	-98.33	-62.22	-61.92	-4,467.76	-3,608.87	-304.71	-358.08
Interest Expense	1	1	3	- -	- -	2	2
Common Equity/Total Assets	-122.51	-69.09	88.96	69.27	70.89	71.43	76.71
Long-Term Debt/Equity (%)	- -	- -	1.84	9.25	9.61	8.34	4.97
Long-Term Debt/Capital (%)	-14.45	-7.41	1.8	8.37	8.66	7.55	4.65
Long-Term Debt/Total Assets (%)	15.4	4.73	1.63	6.41	6.81	5.96	3.81
Total Debt/Equity (%)	-13.01	-7.59	2.11	10.5	10.93	10.48	6.89
Total Debt/Capital (%)	-14.96	-8.22	2.07	9.5	9.86	9.49	6.45
Total Debt/Total Assets (%)	15.94	5.25	1.88	7.27	7.75	7.49	5.29
Net Debt to Equity	46.18	121.01	-52.38	-113.07	-84.25	-54.78	-64.08
Net Debt/Capital (%)	32.24	55.14	-105.6	4,192.65	-318.6	-103.28	-155.66
EBITDA	-60	-81	-174	-234	-326	-443	-564
EBITDA-CapEx	-64	-87	-214	-271	-338	-460	-573
Operating Income (Loss)	-62	-85	-183	-246	-350	-479	-648

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	10.46	11.35	11.07	5.48	4.2	3.17	5.03
Current Ratio	11.43	11.53	11.46	5.68	4.7	3.81	5.5
Quick Ratio	10.48	11.35	11.27	5.51	4.24	3.43	5.2
CFO/Avg Current Liab	- -	-3.05	-4.55	-1.14	-2.98	-2.56	-2.22
Common Equity/Total Assets	-122.51	-69.09	88.96	69.27	70.89	71.43	76.71
Long-Term Debt/Equity (%)	- -	- -	1.84	9.25	9.61	8.34	4.97
Long-Term Debt/Capital (%)	-14.45	-7.41	1.8	8.37	8.66	7.55	4.65
Long-Term Debt/Total Assets (%)	15.4	4.73	1.63	6.41	6.81	5.96	3.81
Total Debt/Equity (%)	-13.01	-7.59	2.11	10.5	10.93	10.48	6.89
Total Debt/Capital (%)	-14.96	-8.22	2.07	9.5	9.86	9.49	6.45
Total Debt/Total Assets (%)	15.94	5.25	1.88	7.27	7.75	7.49	5.29
CFO/Total Liabilities	-25.27	-8.99	-235.31	-38.76	-151.25	-86.8	-108.32
CFO/CapEx	-14.59	-6.74	-3.99	-2.24	-22.93	-21.07	-43.1
Altman's Z-Score	- -	- -	- -	- -	- -	- -	0.15

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	22.23	105.26	2,334.18	- -	- -	- -
Days Sales Outstanding	- -	16.42	3.47	0.16	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	2,467
- Cash & Cash Equivalents	70	262	285	550	392	594	743
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	16	16	11	51	51	108	78
Enterprise Value	- -	- -	- -	- -	- -	- -	1,802
Total Capital	-108	-191	554	537	514	1,143	1,209
Total Debt/Capital (%)	-14.96	-8.22	2.07	9.5	9.86	9.49	6.45
Total Debt / EV	- -	- -	- -	- -	- -	- -	0.04
EV/Sales	- -	- -	- -	- -	- -	- -	24.26
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	2,090
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	1,424
EV per Share	- -	- -	- -	- -	- -	- -	3.41
TTM Sales	2	3	10	40	44	58	74
TTM EBITDA	-60	-81	-174	-234	-326	-443	-564
TTM Operating Income	-62	-85	-183	-246	-350	-479	-648
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	-5.49
EV/EBIT	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	1,802
Low Price	- -	- -	- -	- -	- -	- -	4.67
EV/Sales	- -	- -	- -	- -	- -	- -	24.26
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	2.18
Price/Book Value Average	- -	- -	- -	- -	- -	- -	2.36
Price/Book Value High	- -	- -	- -	- -	- -	- -	2.6
Price/Book Value Low	- -	- -	- -	- -	- -	- -	2.18
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	3.74
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	4.06
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	4.46
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	3.74
Price/Sales	- -	- -	- -	- -	- -	- -	28.14
Price/Sales Average	- -	- -	- -	- -	- -	- -	30.5
Price/Sales High	- -	- -	- -	- -	- -	- -	33.56
Price/Sales Low	- -	- -	- -	- -	- -	- -	28.14
Price/Cash Flow	- -	- -	- -	- -	- -	- -	-5.62
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	-6.09
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	-6.7
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	-5.62
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	-5.95
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	-6.55
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	-5.49
EV/Sales Average	- -	- -	- -	- -	- -	- -	27.04
EV/Sales High	- -	- -	- -	- -	- -	- -	30.65
EV/Sales Low	- -	- -	- -	- -	- -	- -	24.26
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -
Last Price	- -	- -	- -	- -	- -	- -	4.67
High Price	- -	- -	- -	- -	- -	- -	5.57
Enterprise Value Average	- -	- -	- -	- -	- -	- -	2,008
Enterprise Value High	- -	- -	- -	- -	- -	- -	2,276
Enterprise Value Low	- -	- -	- -	- -	- -	- -	1,802

Per Share Data Items (USD)

Per-Share Data API ChatGPT

	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Shares Outstanding	156	156	170	191	234	397	528
Diluted Weighted Avg Shares	112	112	125	176	208	274	447
Basic Weighted Avg Shares	112	112	125	176	208	274	447
Revenue per Share	0.02	0.03	0.08	0.23	0.21	0.21	0.17
EBITDA per Share	-0.53	-0.72	-1.39	-1.33	-1.57	-1.61	-1.26
Operating Income per Share	-0.56	-0.75	-1.46	-1.4	-1.68	-1.75	-1.45
Basic EPS, GAAP	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Basic EPS from Cont Ops	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Diluted EPS, GAAP	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Diluted EPS from Cont Ops	-0.55	-0.77	-1.49	-1.36	-1.58	-1.69	-1.44
Dividend per Share	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.51	-0.4	-1.27	-0.48	-1.38	-1.31	-0.83
Free Cash Flow per Basic Share	-0.54	-0.46	-1.58	-0.69	-1.44	-1.37	-0.85
Cash & Equivalents per Share	0.45	1.68	3.03	2.88	1.67	1.5	1.41
Book Value per Share	-0.8	-1.32	3.19	2.54	1.98	2.61	2.14
Tangible Book Value per Share	-0.8	-1.34	3.18	2.53	1.6	1.39	1.25